Found 5 matching trials
SPI-1005 for the Treatment of Patients With Meniere's Disease
PHASE2This study will evaluate the safety, efficacy, and Pharmacokinetics (PK) of...
SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
PHASE2The primary objective of this study is to determine the safety and efficacy...
Location
Medical University of South Carolina
A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
PHASE2SPI-1005 is a novel oral drug that contains a glutathione peroxidase mimeti...
Location
University of Miami
Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
PHASE1A study to determine the safety, tolerability, and pharmacokinetics of SPI-...
Location
MDS Pharma Services
Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift
PHASE2Exposure to loud sounds can cause hearing loss. The purpose of this researc...
Location
University of Florida